LISA BRAZIL: Open Payments
NPI 1154419117 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $140 |
| Novo Nordisk Inc | 3 | $57 |
| PFIZER INC. | 2 | $39 |
| Corcept Therapeutics | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, Wegovy, SHINGRIX, PREVNAR 20, Korlym, CREON, Kerendia, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
